Mandate

Vinge has assisted Cavotec in connection with listing and admission to trading on NASDAQ OMX Stockholm

October 21, 2011

Cavotec is a global engineering group, supplying innovative and environmentally friendly systems to the ports and maritime, airports, mining and tunnelling and general industry sectors.

Cavotec MSL Holdings Ltd has been listed on the New Zealand Exchange since 2007. In April 2011, the shareholders of Cavotec MSL Holdings Ltd voted in favour of a so called Scheme of Arrangement in order to move the domicile of Cavotec to Switzerland with a new parent company, Cavotec SA. The Board of Directors of Cavotec SA has subsequent to the decision applied for and received approval for listing of Cavotec SA’s shares on NASDAQ OMX Stockholm.

The objective of the listing on NASDAQ OMX Stockholm is to locate the company closer to its main markets and to access a stronger and broader investor base. The last day of trading in the Cavotec MSL Holding Ltd share on the New Zeeland Exchange was 26 September 2011 and the first day of trading in the Cavotec SA share on NASDAQ OMX Stockholm was 19 October 2011.

Vinge’s team has primarily consisted of Göran Nyström, Jesper Schönbeck and Joakim Hagberg and, as regards tax law, Maria Doeser.

Related

Vinge advises Atria Sverige in conjunction with an investment in Cookin Food

Atria Sverige has acquired a 25 per cent stake in the Swedish convenience food company Cookin Food Sweden AB. The transaction has been performed through the acquisition of shares in Bite Delight AB, which owns Cookin Food Sweden AB. Atria holds an option to acquire the remaining shares in Bite Delight AB after 2028.
March 04, 2026

Vinge advises Revivo Group on the acquisition of Solidenergy

Revivo Group, a portfolio company of Helix Kapital, has acquired Solidenergy, a leading provider of surface treatment services in the Norwegian market. The company operates within the energy, offshore and infrastructure sectors and is headquartered in Ågotnes outside Bergen. Solidenergy employs approximately 600 people.
March 03, 2026

Vinge has advised Oncopeptides in connection with its rights issue

Vinge has advised Oncopeptides AB (publ) in connection with a partially guaranteed rights issue which is expected to provide Oncopeptides with proceeds of approximately SEK 200 million before deduction of transaction costs.
March 03, 2026